NCT03221426 2026-03-09
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
945 trialsNCT07453433 2026-03-06
Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Completed
NCT06686966 2026-03-03
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
First Affiliated Hospital of Chongqing Medical University
Completed
NCT03686488 2026-03-02
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT07437573 2026-02-27
KLASS-09
Korea University Guro Hospital
Phase 3 Completed
NCT04426669 2026-02-23
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Phase 1/2 Completed
NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
NCT02248519 2026-02-19
LOGICA
UMC Utrecht
Phase NA Completed
NCT04513223 2026-02-06
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT07387237 2026-02-04
Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
Unidade Local De Saúde Do Norte Alentejano
Completed
NCT03008278 2026-02-03
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT04640480 2026-01-27
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
SN BioScience
Phase 1 Completed
NCT00342654 2026-01-26
Nutrition Intervention Trials in Linxian Follow-up Study
National Institutes of Health Clinical Center (CC)
Completed
NCT06464965 2026-01-26
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
Zhejiang Provincial People's Hospital
Phase 1 Completed
NCT05360680 2026-01-22
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Cue Biopharma
Phase 1 Completed
NCT05641896 2026-01-22
18F-FAPI-74 GI
SOFIE
Phase 2 Completed
NCT04505553 2026-01-21
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
Phase 2 Completed
NCT07340593 2026-01-14
Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study
Zero Helicobacter IGAN Network
Completed
NCT07328633 2026-01-09
Prehabilitation Plus ERAS in Gastric Cancer Surgery
The Affiliated Hospital of Qingdao University
Phase NA Completed
NCT03611309 2026-01-08
PERIOP-PC
Stanford University
Phase NA Completed
NCT05419362 2025-12-16
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
Genome & Company
Phase 2 Completed
NCT06981819 2025-12-16
Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy
Changhai Hospital
Completed
NCT04157985 2025-12-11
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Phase 3 Completed
NCT04798781 2025-12-11
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Cedars-Sinai Medical Center
Phase 2 Completed
NCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
NCT06452329 2025-12-04
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
Bristol-Myers Squibb
Completed
NCT07155330 2025-11-25
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Zhejiang University
Phase NA Completed
NCT07243847 2025-11-24
Recurrence and Prognosis Prediction Model for Gastric Cancer
Fudan University
Completed
NCT07244471 2025-11-24
Water-injecting Endoscopic Submucosal Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Completed
NCT05472532 2025-11-20
INOVOLINE
Hospices Civils de Lyon
Phase NA Completed
NCT06023966 2025-11-20
A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery
Tianjin Medical University Cancer Institute and Hospital
Completed
NCT01191697 2025-11-03
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT04208958 2025-10-27
ConsortiumIO
Vedanta Biosciences, Inc.
Phase 1/2 Completed
NCT03819088 2025-10-09
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
Emory University
Phase NA Completed
NCT07211880 2025-10-08
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
Zero Helicobacter IGAN Network
Phase NA Completed
NCT07213115 2025-10-08
Epidemiology and Treatment of Gastric Cancer
Medizinische Hochschule Brandenburg Theodor Fontane
Completed
NCT04526886 2025-10-06
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT02738294 2025-10-02
Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB
Shanghai Jiao Tong University School of Medicine
Phase NA Completed
NCT04768686 2025-09-25
FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
Hanmi Pharmaceutical Company Limited
Phase 2 Completed
NCT05104567 2025-09-24
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
Sanofi
Phase 2 Completed
NCT05644249 2025-09-24
PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer
Vilnius University
Phase NA Completed
NCT07190040 2025-09-24
Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy
Fujian Medical University
Completed
NCT06339307 2025-09-18
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
Tianjin Medical University Cancer Institute and Hospital
Completed
NCT07177560 2025-09-17
DICLO-HFS
Gazi University
Completed
NCT03813784 2025-09-16
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT03929666 2025-09-12
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals
Phase 2 Completed
NCT04892342 2025-09-12
Study of ESG401 in Adults With Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd
Phase 1/2 Completed
NCT04772989 2025-08-28
ARC-12
Arcus Biosciences, Inc.
Phase 1 Completed
NCT06582849 2025-08-26
EARN
Washington University School of Medicine
Phase NA Completed
NCT06585501 2025-08-21
REHEARSAL
Daiichi Sankyo
Completed